Skip to main content
Premium Trial:

Request an Annual Quote

Brady Davis, John Ellithorpe

DNAnexus expands its executive leadership team by appointing Brady Davis as vice president of strategy and marketing and John Ellithorpe as chief product officer. Davis comes to DNAnexus from Illumina, where he identified investment and acquisition opportunities, developed strategic partnerships, and led global product marketing for informatics. Before his work at Illumina, he led business development, strategy, and innovation for Oracle's Health Science Global Business Unit. Ellithorpe joins Illumina from Vantiq, where he served as chief product officer. Before his work at Vantiq, he co-founded Model N, where he served as chief technology officer and chief product officer.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.